ArticleJNCI cancer spectrum2021

A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker.

Iakovos Toumazis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.